Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
10 Agosto 2023 - 5:10PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to
Section 14(a) of
the Securities Exchange Act
of 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
|
☐ |
Preliminary Proxy Statement |
|
☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
☐ |
Definitive Proxy Statement |
|
☒ |
Definitive Additional Materials |
|
☐ |
Soliciting Material under §240.14a-12 |
Moringa Acquisition Corp
(Name of Registrant as Specified
In Its Charter)
(Name of Person(s) Filing
Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
☒ |
No fee required. |
|
☐ |
Fee paid previously with preliminary materials. |
|
☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11 |
On August 10, 2023, Moringa
Acquisition Corp (“Moringa”) filed with the Securities and Exchange Commission a Current Report on Form 8-K
(a “Form 8-K”) reporting the termination of the Business Combination Agreement (as amended, the “Business
Combination Agreement”), dated as of June 9, 2022, to which it was party with Holisto Ltd., an Israeli company. Despite
the termination of the Business Combination Agreement, Moringa plans to seek approval for all proposals set forth in the proxy statement
for its upcoming Extraordinary General Meeting in lieu of 2023 Annual General Meeting, which is scheduled to take place on Wednesday,
August 16, 2023. Specifically, Moringa will seek to extend the deadline for completion of an initial business combination under its amended
and restated memorandum and articles of association to August 19, 2024 (or such earlier date as Moringa’s board of directors may
determine), in order to pursue other potential business combination opportunities.
The text of the subject Form
8-K is set forth below:
Item 1.02. Termination of Material Definitive Agreement
On August 7, 2023, Moringa Acquisition Corp, a Cayman
Islands exempted company (“Moringa” or the “SPAC”) received from Holisto Ltd., an
Israeli company (“Holisto”), a notice that stated that Holisto was terminating the Business Combination Agreement
(as amended, the “Business Combination Agreement”), dated as of June 9, 2022, by and among Moringa, Holisto,
and Holisto MergerSub, Inc., a Cayman Islands exempted company and wholly-owned subsidiary of Holisto (“Merger Sub”).
Pursuant to the termination notice, effective as of the end of the day on August 8, 2023, all rights and obligations of each party to
the Business Combination Agreement ceased, except for the obligations of each party to the Business Combination Agreement that were intended
to survive such termination, in accordance with the applicable provisions of the Business Combination Agreement, which surviving obligations
shall remain in effect in accordance with their respective terms.
The termination notice was provided by Holisto in accordance
with Section 7.1(j) of the Business Combination Agreement, under which either Moringa or Holisto could terminate the agreement upon notice
to the other party, given that the business combination between the parties was not consummated on or prior to January 1, 2023.
For more information concerning the Business Combination Agreement please
see the text of the agreement, which was previously filed as Exhibit 2.1 to Moringa’s Current Report on Form 8-K filed with
the SEC on June 13, 2022, as amended by (a) Amendment No. 1 to the Business Combination Agreement, which was previously filed as Exhibit
10.1 to Moringa’s Current Report on Form 8-K filed with the SEC on August 17, 2022, and (b) Amendment No. 2 to the Business Combination
Agreement, which was previously filed as Exhibit 10.1 to Moringa’s Current Report on Form 8-K filed with the SEC on January 4, 2023,
each of which is incorporated by reference herein.
Moringa Acquisition (NASDAQ:MACAU)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025
Moringa Acquisition (NASDAQ:MACAU)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025